Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr;3(4):530-545.
doi: 10.1038/s42255-021-00363-1. Epub 2021 Mar 25.

A genetic map of the mouse dorsal vagal complex and its role in obesity

Affiliations

A genetic map of the mouse dorsal vagal complex and its role in obesity

Mette Q Ludwig et al. Nat Metab. 2021 Apr.

Abstract

The brainstem dorsal vagal complex (DVC) is known to regulate energy balance and is the target of appetite-suppressing hormones, such as glucagon-like peptide 1 (GLP-1). Here we provide a comprehensive genetic map of the DVC and identify neuronal populations that control feeding. Combining bulk and single-nucleus gene expression and chromatin profiling of DVC cells, we reveal 25 neuronal populations with unique transcriptional and chromatin accessibility landscapes and peptide receptor expression profiles. GLP-1 receptor (GLP-1R) agonist administration induces gene expression alterations specific to two distinct sets of Glp1r neurons-one population in the area postrema and one in the nucleus of the solitary tract that also expresses calcitonin receptor (Calcr). Transcripts and regions of accessible chromatin near obesity-associated genetic variants are enriched in the area postrema and the nucleus of the solitary tract neurons that express Glp1r and/or Calcr, and activating several of these neuronal populations decreases feeding in rodents. Thus, DVC neuronal populations associated with obesity predisposition suppress feeding and may represent therapeutic targets for obesity.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Bray, G. A. Medical treatment of obesity: the past, the present and the future. Best Pract. Res. Clin. Gastroenterol. 28, 665–684 (2014). - PubMed - DOI
    1. Bray, G. A., Frühbeck, G., Ryan, D. H. & Wilding, J. P. H. Management of obesity. Lancet 387, 1947–1956 (2016). - PubMed - DOI
    1. Schwartz, M. W. et al. Obesity pathogenesis: an endocrine society scientific statement. Endocr. Rev. 38, 267–296 (2017). - PubMed - PMC - DOI
    1. O’Rahilly, S. & Farooqi, I. S. Genetics of obesity. Philos. Trans. R. Soc. Lond. B Biol. Sci. 361, 1095–1105 (2006). - PubMed - PMC - DOI
    1. Srivastava, G. & Caroline, M. Current pharmacotherapy for obesity. Nat. Rev. Endocrinol. 14, 12–24 (2018). - PubMed - DOI

Publication types

MeSH terms